Design considerations for PAMAM dendrimer therapeutics

Sascha N Goonewardena1, Jeremy D Kratz, Hong Zong

  • 1Michigan Nanotechnology Institute for Medicine and Biological Sciences, Ann Arbor, MI 48109, USA. sngoonew@med.umich.edu

Summary

We developed novel polymer therapeutics by linking methotrexate (MTX) to dendrimers using click chemistry. Ester-linked MTX-dendrimers showed higher cancer cell killing than amide-linked versions, improving therapeutic design.